Tuberculosis and Respiratory Diseases

Search

Page Path

Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy.: Jae Hoon Song, Ki Suck Jung, Moon Won Kang, Do Jin Kim, Hyunjoo Pai, Gee Young Suh, Tae Sun Shim, Joong Hyun Ahn, Chul Min Ahn, Jun Hee Woo, Nam Yong Lee, Dong Gun Lee, Mi Suk Lee, Sang Moo Lee, Yeong Seon Lee, Hyukmin Lee, Doo Ryeon Chung; Tuberc Respir Dis. 2009;67(4):281-302. Published online October 1, 2009; DOI: https://doi.org/10.4046/trd.2009.67.4.281
Crossref 21; PDF

Factors Associated with Residual Pleural Thickening After Chemotherapy in Tyberculous Pleurisy.: Ki Man Lee, Jong Joon Ahn, Kwang Won Seo, Jee Hyun Park, Mi Suk Lee, Jae Cheol Hwang; Tuberc Respir Dis. 2001;50(5):607-614. Published online May 1, 2001; DOI: https://doi.org/10.4046/trd.2001.50.5.607
Crossref 1; PDF

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

MOST VIEWED MOST CITED

20,100	Clonal Hematopoiesis of Indeterminate Potential Is Associated with Current Smoking Status and History of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease
7,755	Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis
3,545	Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid Cultures
2,619	Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
3,331	Tuberculosis Notification and Incidence: Republic of Korea, 2022

Cited By 25	Tuberculosis: Republic of Korea, 2021
Cited By 13	Improving Tuberculosis Medication Adherence: The Potential of Integrating Digital Technology and Health Belief Model
Cited By 12	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
Cited By 6	New Targeted Therapy for Non-Small Cell Lung Cancer
Cited By 6	Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org